USE OF DOPAMINE STABILIZERS

摘要

The present invention relates to the use of a dopamine stabilizing substance in an oral, subcutaneous or intramuscular daily dose of 1 -20 mg or in an intravenous daily dose of 0.1 -2 mg in treatment of a neurological or psychiatric disorder characterized by a hypofunction of the dopamine system. The invention also relates to the use of a dopamine stabilizing substance in an oral, subcutaneous or intramuscular daily dose of 25-50 mg in treatment of a disorder caused by instability of neural circuits.